Ovarian Cancer - Nov 15, 2023 - Study shows combined genomic screening for major hereditary diseases is cost-effective and health-saving

Can't see this email? View it online

	Ovarian Cancer
	The latest ovarian cancer news from News Medical

	Australian study shows combined genomic screening for major hereditary diseases is cost-effective and health-saving In an Australian study published in EClinicalMedicine, researchers evaluated the impact of a combined genomic screening program for hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia in young adults. The program proved to be cost-effective, reducing healthcare costs and averting numerous health events, while emphasizing the need for further optimization and equitable access within public healthcare systems.

	Newly identified small molecule can suppress growth of breast and ovarian cancers in animal models Researchers at Baylor College of Medicine have identified a small molecule named 5D4 that can suppress the growth of breast and ovarian cancers in animal models.

A prospective path for allogeneic cellular immunotherapies.

	CAR-NK: The next generation in hematological malignancy treatment This article delves into the scientific intricacies of CAR-NK therapy, offering insights into its potential as a safer and more effective cancer immunotherapy strategy.

	AI-based model can predict therapy outcome in ovarian cancer patients A model based on artificial intelligence is able to predict the therapy outcome (measured by volumetric reduction of tumor lesions) in 80% of ovarian cancer patients.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions